Inhaler Market 2021 Growth, COVID Impact, Trends Analysis Report 2027
The global smart inhaler market is expected to grow substantially over the forecast period. Increasing prevalence of asthma and COPD is one of the major factors that is driving the market growth. Moreover, the emergence and implementation of IoT and connected devices have also paved its way in the medical device industry. It has enabled the efficient convergence of the medical industry across the globe. Due to this, smart inhalers have gained much recognition in recent years. Sensors in inhalers track the usage of medications and transmit reminders to the patients at the time of their medication. This enables patients to promote and monitor adherence as a self-management plan for disease control.
To Request a Sample of our Report on Inhaler Market: https://www.omrglobal.com/request-sample/inhaler-market
The trend towards smart inhalers is encouraging
healthcare providers to focus on this digital technology for the effective
treatment of patients suffering from respiratory diseases. Owing to this, many
healthcare providers are entering the global smart inhaler industry. For
instance, in August 2018, Adherium Ltd., a digital platform provider for
medication, partnered with Vitalus Health, a pulmonary healthcare treatment
provider to focus on managing physicians' and patients' needs for smart
inhalers. The agreement is intended to leverage capabilities for the
development of health outcomes. Adherium’s Halie solution comprises a sensor that
is fixed to the patient’s COPD or asthma inhaler medication and software. This
includes an online web portal and an app for both clinicians and
patients.
Major partnerships and collaborations between
players have been observed in the smart inhalers market which is expanding
market size for smart inhalers globally. The agreements are enabling the smart
inhaler makers and partners to expand their product range, introduce new
technology to their existing product range, and increase their sales. For instance,
in February 2017, Novartis AG signed a connected inhaler agreement with
Propeller Health that would connect Breezhaler devices of the company with a
digital platform of Propeller. This is aimed at aiding the patients and their
doctors in monitoring adherence and other treatment factors.
Moreover, in August 2017, Propeller Health extended
its collaboration with GlaxoSmithKline to progress in managing asthma and COPD.
The companies decided to continue their R&D work. In February 2017, the
company collaborated with Novartis Pharma AG to develop custom add-on sensors
for Breezhaler. It is a device used for COPD treatments. In May 2016, the
company established a partnership with Molina Healthcare to focus on medication
adherence and to reduce the symptoms of asthma. Additionally, in the same
month, GlaxoSmithKline partnered with Propeller Health, which provides a
digital solution for respiratory medicine. Both the companies expanded their
collaboration from 2015, for digital Ellipta inhaler.
Current Market Trends Covered in the Global Smart
Inhaler Market Report
·
Asia-Pacific is expected to gain maximum traction in the
global smart inhaler market during the forecast period.
·
Based on the application segment, asthma is expected to
hold the largest market share over the forecast period.
(Get 15% Discount on Buying this Report)
A
full Report of Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/inhaler-market
Global Smart Inhaler Market Segmentation
By Product Type
·
Metered Dose Inhaler
·
Dry Powder Inhaler
By Application
·
Asthma
·
COPD
·
By End-User
·
Hospitals and Clinics
·
Homecare
Global Smart Inhaler Market – Segment by Region
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
3M
·
Agilent Technologies, Inc.
·
AstraZeneca
·
Bespak Europe Ltd
·
Beximco Pharmaceuticals Ltd.
·
Boehringer Ingelheim International GmbH
·
Cipla Inc.
·
DeVilbiss Healthcare LLC
·
GENERAL ELECTRIC CO.
·
GlaxoSmithKline plc.
·
Glenmark Pharmaceutical Inc.
·
Hovione
·
Lupin
·
MannKind Corp.
·
Manta Devices LLC
·
MidasCare.
·
Novartis AG
·
Omega Life Science Ltd.
·
Omron Healthcare Europe B.V.
·
Koninklijke Philips N.V.,
·
Propeller Health
·
PULMATRiX, Inc.
·
Savara Inc.
·
Teicos Pharma Ltd
·
TEIJIN Ltd.
·
Teva Pharmaceutical Industries Ltd.
·
Vitalograph
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert research
analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment